Login or sign up
For business

Gloucester Pharmaceuticals

3.9· 9 reviews
Average ratingAverage
3.9/ 5

Based on 9 reviews

533%
422%
344%
20%
10%
Ask AI

Ask AI about Gloucester Pharmaceuticals

Generated with AI from 9 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Angus Quinn
Reviews 1

I had an average experience with Gloucester Pharmaceuticals. The customer service was decent and the product quality was satisfactory. However, I did not find anything exceptional about them. The website, gloucesterpharma.com, was easy to navigate and provided all the necessary information.

Will Ulmer
Reviews 1

I had an average experience with Gloucester Pharmaceuticals. The customer service was decent and the product quality was satisfactory. However, I did not find anything exceptional about them. The website, gloucesterpharma.com, was easy to navigate and provided all the necessary information.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Gloucester Pharmaceuticals

Gloucester Pharmaceuticals is a biopharmaceutical company owned by [Celgene](/organization/celgene) that acquires clinical-stage oncology drug candidates with the goal of advancing them through regulatory approval and commercialization. Gloucester's first compound, romidepsin, is a late-stage oncology drug candidate that has shown potential activity across a range of hematological malignancies. The Company retains worldwide exclusive rights to romidepsin, an oncology candidate within a new class of anti-cancer agents known as histone deacetylase (HDAC) inhibitors. Preclinical studies suggest that romidepsin is a potent inhibitor of Class I, Class II and Class IV HDACs.